Literature DB >> 10507694

Heterologous expression of a green fluorescent protein-pertussis toxin S1 subunit fusion construct disrupts calcium channel modulation in rat superior cervical ganglion neurons.

S R Ikeda1, S W Jeong, P J Kammermeier, V Ruiz-Velasco, M M King.   

Abstract

The fusion construct pEGFP-PTXS1 was assembled by ligating cDNA encoding the S1 subunit of Bordetella pertussis toxin (PTX) into the plasmid pEGFP-C1 (which codes for enhanced green fluorescent protein). Microinjection of pEGFP-PTXS1 (1-100 ng/microl) into the nucleus of dissociated rat sympathetic ganglion neurons resulted in functional expression as determined from the diffuse green fluorescence and disruption of norepinephrine-mediated N-type Ca2+ channel modulation. The heterologously expressed toxin retained specificity for G alpha(i/o)-dependent pathways as VIP-mediated modulation of N-type Ca2+ channels and muscarine-mediated inhibition of M-type K+ channels persisted in pEGFP-PTXS1 expressing neurons. These data demonstrate that the S1 subunit of PTX is readily expressed in mammalian neurons and remains functional following fusion to the C-terminus of another protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507694     DOI: 10.1016/s0304-3940(99)00555-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Silencing GIRK4 expression in human atrial myocytes by adenovirus-delivered small hairpin RNA.

Authors:  Xiongtao Liu; Jian Yang; Fujun Shang; Changming Hong; Wangang Guo; Bing Wang; Qiangsun Zheng
Journal:  Mol Biol Rep       Date:  2008-07-18       Impact factor: 2.316

2.  Phosphorylation barcode-dependent signal bias of the dopamine D1 receptor.

Authors:  Ali I Kaya; Nicole A Perry; Vsevolod V Gurevich; T M Iverson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-05       Impact factor: 11.205

3.  Functional and pharmacological characteristics of metabotropic glutamate receptors 2/4 heterodimers.

Authors:  Paul J Kammermeier
Journal:  Mol Pharmacol       Date:  2012-05-31       Impact factor: 4.436

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.